Delivery Order SPE2DE24DA017-SPE2D625F1QVL
- Not listed
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies, was awarded a fixed-price delivery order valued at $3,029.40 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for the ACP MAX PRP System with ACDA. The delivery order, which is not set-aside for any specific business category, has an ultimate completion date of July 29, 2025, and will be performed in Naples, Florida. This award represents a task order under Arthrex's broader Indefinite...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $52,879.14 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for an ACP MAX PRP System with ACDA technology. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract carries no set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $3,025.44 delivery order on August 1, 2025, with an ultimate completion date of August 6, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal program supporting government healthcare systems. The contract carries no set-aside designation, reflecting Arthrex's competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,540.80 for an ACP Kit Series I on August 12, 2025, with an ultimate completion date of August 15, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for distributing medical supplies to Department of Defense and Department of Veterans...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $17,602.20 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for ARTHREX ACP DOUBLE 1S products. This delivery order, without set-aside designation, is expected to be completed by August 27, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency,...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies, received a $3,300 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the Arthrex ACP Double Syringe System. The contract, which carries an ultimate completion date of September 3, 2025, represents a task order issued against Arthrex's substantial indefinite delivery contract with the Defense Logistics Agency valued at approximately $471...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $2,070.84 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on June 30, 2025. The delivery order, designated as SP FBRTAK RC TGRTPE WH/BLK & STTPE WH/BL, calls for specialized orthopedic products with an ultimate completion date of July 3, 2025. This award was not set aside for any specific business type, reflecting Arthrex's strong competitive...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $2,475 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment capability was awarded on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract represents no set-aside designation,...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies based in Naples, Florida, received a delivery order valued at $6,586.92 from the Defense Logistics Agency's Medical Supply Chain on August 5, 2025. This fixed-price delivery order with economic price adjustment, designated as IMPL SYS, MPFL, FASTTHREAD, represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F1QVLDelivery Order
Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,111.90 on August 22, 2025, under a fixed-price contract with economic price adjustment provisions. The order, identified as 4569186034 and titled "ACP MAX PRP SYSTEM (W/ ACDA)," is scheduled for completion by August 27, 2025, with performance to be executed in Naples, Florida. This delivery order was issued without a set-aside designation, reflecting Arthrex's competitive standing in the federal marketplace. The order is funded through the Defense Logistics Agency's Medical Supply Chain, a defense agency responsible for supplying medical products and equipment to the Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order falls under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running through September 2029. This comprehensive IDC enables VA medical centers and military healthcare facilities across the nation to procure Arthrex's portfolio of orthopedic surgical technologies, including implants, arthroscopic instruments, and specialized surgical kits. The ACP MAX PRP System delivery represents the company's continued provision of advanced orthopedic solutions to support the healthcare requirements of veterans and military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/22/25 |